References
- Berger Z, Ravikumar B, Menzies FM, Oroz LG, Underwood BR, Pangalos MN, . Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum Mol Genet 2006;15:433–442.
- Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254.
- Forno LS. Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 1996;55:259–272.
- Geisler S, Holmstrom KM, Skujat D, Fiesel FC, Rothfuss OC, Kahle PJ, . PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 2010;12:119–131.
- Hardy J, Cookson MR, Singleton A. Genes and parkinsonism. Lancet Neurol 2003;2:221–228.
- Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, . Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392:605–608.
- Kroemer G, Marino G, Levine B. Autophagy and the integrated stress response. Mol. Cell 2010;40:280–293.
- Kumar MJ, Andersen JK. Perspectives on MAO-B in aging and neurological disease: where do we go from here? Mol Neurobiol 2004;30:77–89.
- Kumar MJ, Nicholls DG, Andersen JK. Oxidative alpha-ketoglutarate dehydrogenase inhibition via subtle elevations in monoamine oxidase B levels results in loss of spare respiratory capacity: implications for Parkinson's disease. J Biol Chem 2003;278:46432–46439.
- Langston JW, Ballard PA Jr. Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. N Engl J Med 1983;309:310.
- Lavoie MJ, Cortese GP, Ostaszewski BL, Schlossmacher MG. The effects of oxidative stress on parkin and other E3 ligases. J Neurochem 2007;103:2354–2368.
- Moore DJ. Parkin: a multifaceted ubiquitin ligase. Biochem Soc Trans 2006;34:749–753.
- Olanow CW, McNaught KS. Ubiquitin-proteasome system and Parkinson's disease. Mov Disord 2006;21:1806–1823.
- Pan T, Kondo S, Le W, Jankovic J. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. Brain 2008;131:1969–1978.
- Qin ZH, Wang Y, Kegel KB, Kazantsev A, Apostol BL, Thompson LM, . Autophagy regulates the processing of amino terminal huntingtin fragments. Hum Mol Genet 2003;12:3231–3244.
- Ravikumar B, Berger Z, Vacher C, O'Kane CJ, Rubinsztein DC. Rapamycin pre-treatment protects against apoptosis. Hum Mol Genet 2006;15:1209–1216.
- Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, Schneider R, . Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science 2001;293:263–269.
- Siddiqui A, Mallajosyula JK, Rane A, Andersen JK. Ability to delay neuropathological events associated with astrocytic MAO-B increase in a Parkinsonian mouse model: implications for early intervention on disease progression. Neurobiol Dis 2010;40:444–448.
- Sies H. Role of reactive oxygen species in biological processes. Klin Wochenschr 1991;69:965–968.
- Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M, . Alpha-synuclein in Lewy bodies. Nature 1997;388:839–840.
- Tain LS, Mortiboys H, Tao RN, Ziviani E, Bandmann O, Whitworth AJ, . Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss. Nat Neurosci 2009;12:1129–1135.
- Tanaka A. Parkin-mediated selective mitochondrial autophagy, mitophagy: Parkin purges damaged organelles from the vital mitochondrial network. FEBS Lett 2010;584: 1386–1392.
- Thomas B, Beal MF. Parkinson's disease. Hum Mol Genet 2007;16(Spec No. 2):R183–R194.
- Trounce IA, Kim YL, Jun AS, Wallace DC. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol 1996;264:484–509.
- Zid BM, Rogers AN, Katewa SD, Vargas MA, Kolipinski MC, Lu TA, . 4E-BP extends lifespan upon dietary restriction by enhancing mitochondrial activity in Drosophila. Cell 2009;139:149–160.